XML 28 R12.htm IDEA: XBRL DOCUMENT
v3.20.2

Balance Sheets-Additional Information | 3 Months Ended
--- | ---
Sep. 30, 2020
Balance Sheets Additional Information |
Balance Sheets-Additional Information | 4. Balance Sheets—Additional Information ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, | ​ | June 30,
As of |  | 2020 |  | 2020
Inventories | ​ | ​ | ​ | ​ | ​ |
Raw materials | ​ | $ | 67,499 | ​ | $ | 73,837
Work-in-process | ​ | ​ | 10,336 | ​ | ​ | 8,881
Finished goods | ​ | ​ | 128,011 | ​ | ​ | 113,941
​ | ​ | $ | 205,846 | ​ | $ | 196,659
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | June 30,
As of |  | 2020 |  | 2020
Goodwill roll-forward |  | ​ |  | ​ |  |
Balance at beginning of period |  | $ | 52,679 | ​ | $ | 27,348
Osprey acquisition |  | ​ | — | ​ |  | 25,331
Balance at end of period |  | $ | 52,679 | ​ | $ | 52,679
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, | ​ | June 30,
As of |  | 2020 |  | 2020
Other assets | ​ | ​ | ​ | ​ | ​ | ​
ROU operating lease assets | ​ | $ | 22,089 |  | $ | 22,873
Deferred income taxes | ​ |  | 11,368 |  | ​ | 11,430
Deposits | ​ |  | 5,042 |  | ​ | 5,158
Insurance investments | ​ |  | 5,891 |  | ​ | 5,801
Equity method investments | ​ |  | 4,367 |  | ​ | 4,219
Indemnification asset | ​ |  | — |  | ​ | 3,000
Debt issuance costs | ​ |  | 893 |  | ​ | 1,021
Other | ​ |  | 6,895 |  | ​ | 6,976
​ | ​ | $ | 56,545 |  | $ | 60,478
​ We evaluate our investments in equity method investees for impairment if circumstances indicate that the fair value of the investment may be impaired. The assets underlying a $2,988 equity investment are currently idled; we have concluded that the investment is not currently impaired, based on expected future operating cash flows and/or disposal value. ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | June 30,
As of | ​ | 2020 | ​ | 2020
Accrued expenses and other current liabilities |  | ​ |  |  | ​ |
Employee related | ​ | $ | 24,789 | ​ | $ | 25,825
Current operating lease liabilities | ​ |  | 6,471 | ​ |  | 6,439
Commissions and rebates | ​ | ​ | 4,259 | ​ | ​ | 5,782
Professional fees | ​ |  | 5,822 | ​ |  | 5,766
Income and other taxes | ​ | ​ | 5,245 | ​ | ​ | 3,821
Derivatives | ​ | ​ | 5,930 | ​ | ​ | 5,757
Contingent consideration | ​ |  | 4,840 | ​ |  | —
Restructuring costs | ​ |  | 2,029 | ​ |  | 2,314
Insurance-related | ​ |  | 1,267 | ​ |  | 1,272
Other | ​ |  | 17,491 | ​ |  | 15,421
​ | ​ | $ | 78,143 | ​ | $ | 72,397
​ In connection with productivity and cost-saving initiatives in the Animal Health segment, we incurred business restructuring costs related to the termination of a contract manufacturing agreement and employee separation charges. All actions have been executed as of September 30, 2020. The following table summarizes the activity of the restructuring liability during the three months ended September 30, 2020: ​
​ | ​ | ​ | ​
Liability balance at June 30, 2020 |  | $ | 2,860
Charges | ​ |  | —
Payments | ​ |  | (831)
Liability balance at September 30, 2020 | ​ | $ | 2,029
​ As of September 30, 2020, $1,600 and $429 of the liability balance related to contract termination and employee separation costs, respectively. ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | September 30, |  | June 30,
As of |  | 2020 |  | 2020
Other liabilities | ​ | ​ | ​ | ​ | ​ | ​
Long-term operating lease liabilities | ​ | $ | 16,366 | ​ | $ | 17,276
Long term and deferred income taxes | ​ |  | 10,867 | ​ | ​ | 11,680
Derivatives | ​ | ​ | 6,429 | ​ | ​ | 7,691
Supplemental retirement benefits, deferred compensation and other | ​ | ​ | 8,199 | ​ | ​ | 8,067
Contingent consideration | ​ | ​ | — | ​ | ​ | 4,840
International retirement plans | ​ |  | 5,576 | ​ |  | 5,499
U.S. pension plan | ​ |  | 2,918 | ​ |  | 3,563
Restructuring costs | ​ |  | — | ​ |  | 546
Other long term liabilities | ​ |  | 7,735 | ​ |  | 11,239
​ | ​ | $ | 58,090 | ​ | $ | 70,401
​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, |  | June 30,
As of |  | 2020 |  | 2020
Accumulated other comprehensive income (loss) | ​ | ​ |  | ​ | ​ |
Derivative instruments | ​ | $ | (12,359) | ​ | $ | (13,448)
Foreign currency translation adjustment | ​ |  | (108,461) | ​ |  | (103,738)
Unrecognized net pension gains (losses) | ​ |  | (22,436) | ​ |  | (22,571)
(Provision) benefit for income taxes on derivative instruments | ​ |  | 2,984 | ​ |  | 3,256
(Provision) benefit for incomes taxes on long-term intercompany investments | ​ | ​ | 8,166 | ​ | ​ | 8,166
(Provision) benefit for income taxes on pension gains (losses) | ​ | ​ | (2,084) | ​ | ​ | (2,050)
​ | ​ | $ | (134,190) | ​ | $ | (130,385)
​

X
- References No definition available. + Details
Name: | pahc_BalanceSheetsAdditionalInformationAbstract
Namespace Prefix: | pahc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -URI http://asc.fasb.org/topic&trid=2122208 + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration